Leukogen

Leukogen: description, indications for use and contraindications

Leukogen is a drug produced in Russia by a pharmaceutical group of metabolic stimulants - pyrimidine and thiazoline derivatives. The drug is produced by ICN October and is presented in the form of tablets with a dosage of 20 mg. The international name of the drug is Leukogen.

The main active ingredient of the drug is leukogen. The drug is used for the treatment of leukopenia, including in patients undergoing X-ray, radio and chemotherapy for malignant neoplasms, agranulocytic tonsillitis, and alimentary-toxic aleukia.

Contraindications to the use of the drug Leukogen include hypersensitivity to the active substance, lymphogranulomatosis and malignant diseases of the hematopoietic organs. Caution should be exercised when using the drug in patients with impaired renal and liver function, as well as during pregnancy and breastfeeding.

Side effects from using the drug may include allergic reactions. There is no data on the interaction of the drug Leukogen with other drugs, and there is also no information on overdose and special instructions.

The 2006 Encyclopedia of Drugs is a source of information about this drug.

In conclusion, Leukogen is an effective treatment for leukopenia, but should not be used if there are contraindications. Before starting to use the drug, you must consult a specialist and strictly follow the recommendations for dosage and use.